Sun Pharma Surpasses SBI in Market Valuation

Subscribe to GoodReturns
For Quick Alerts
For Daily Alerts

    Drug major Sun Pharmaceutical Industries on Tuesday surpassed SBI, country's largest public sector lender, in terms of market valuation.

    Sun Pharma's market capitalisation (m-cap) increased to Rs 2,15,394.82 crore, following over one per cent rally in the stock at the BSE, overtaking SBI whose valuation stood at Rs 2,09,488.41 crore during the afternoon trade.

    Sun Pharma Surpasses SBI in Market Valuation

    SBI's scrip was trading 0.48% lower at Rs 280.30.

    With this, Sun Pharma now stands at 8th position in the list of top-10 most valued companies in terms of their market capitalisation, followed by SBI at ninth place.

    TCS is the most valued Indian company with a market cap of Rs 5,04,068.85 crore, followed by RIL, ITC, ONGC, HDFC Bank, Infosys, CIL, Sun Pharma, SBI and HDFC.

    Market capitalisation of a listed company corresponds to the cumulative market price of all its shares. This figure changes daily with change in stock price.


    Read more about: sun pharma sbi
    Story first published: Tuesday, March 17, 2015, 14:32 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more